Searched for
BIOPHARMACEUTICAL FIRM
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- “Not Australia, but India rejected me for being a woman”: Kiran Mazumdar-Shaw clarifies how gender bias led her to build Biocon in viral postBiocon founder Kiran Mazumdar-Shaw intervened and clarified after a viral post claimed that Australia denied her a master brewer role due t...
- Global Market: Hong Kong IPO boom draws rising interest from overseas companiesHong Kong's stock market is seeing more foreign companies file for listings. Firms from countries like Indonesia and South Korea are explor...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- US stock market futures today: Why are Dow Jones and S&P 500 in red while Nasdaq turns green today? Dow drops 280 points as oil tops $120— can AI spending offset rising inflation fears and Fed uncertainty?Why are Dow Jones and S&P 500 in red while Nasdaq turns green today? The US stock market futures today are sending a sharp, layered signal....
- AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 croreThe land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva...
- China pulls ahead in biologics race, forcing Indian drugmakers to rethink strategyIndia's drug companies face a tough race in the global biologics market. China is quickly becoming a leader in biotech supply chains. India...
- Cambridge graduate ditches high-paying job for zookeeping: Here’s why she chose to care for animals over a fat paychequeMa Ya, a 25-year-old Chinese woman with degrees from Imperial College London and the University of Cambridge, left her high-paying job to b...
- GSK to buy US biotech firm IDRx for up to $1.15 billionBritish drugmaker GSK agrees to acquire Boston-based biopharmaceutical firm IDRx for up to $1.15 billion, with an initial $1 billion paymen...
- Sun Pharma subsidiary partners with Aclaris Therapeutics for licensing agreementAs per the pact, Aclaris grants Sun Pharma exclusive rights to specific patents for using deuruxolitinib, Sun Pharma's JAK inhibitor, or ot...
- Biocon founder Kiran Mazumdar-Shaw's husband, John Shaw, passes awayBorn in 1949, Shaw served as the Vice Chairman and non-executive director of Biocon and has been on the board since 1999. He was the foreig...
- Gland Pharma buys Vitane’s assets to scale up production of Sputnik VVitane Biologics, with around 100 personnel, has a dedicated research and development facility and a manufacturing plant to handle both mic...
- Alembic Pharma arm inks pact with Curon to develop cancer treatment drug in Greater ChinaAs per the agreement, Rhizen will receive an undisclosed upfront cash payment and is eligible to receive additional development and commerc...
- Natco Pharma's Canadian unit signs pact with Celgene for cancer treatment drugNatco Pharma entered into an agreement with biopharmaceutical firm Celgene for Lenalidomide capsules, which is used to treat various types ...
- CCI approves Mitsui's 26% stake buy in Arch PharmalabsCompetition Commission of India (CCI) has approved Japanese firm Mitsui's proposed takeover of 26.71 per cent stake in domestic biopharmace...
- GE Healthcare to acquire PAA LaboratoriesGE Healthcare said that it has reached an agreement to acquire PAA Laboratories that develops and supplies cell culture media for biomedica...
- Cadila Healthcare to set up bio-technology plant in GujPharmaceutical firm Cadila Healthcare will set up a bio-technology plant here with an investment of Rs 25 crore for manufacturing biosimila...
- Novartis eyes buy-out of biopharma firm SpeedelSwiss pharmaceutical giant Novartis said it had boosted its stake in biopharmaceutical firm Speedel by 51.7 per cent and aimed to buy it ou...
- US co Jacob to buy stake in AvesthagenUS-based private equity firm Jacob Ballas Capital (JBC) is close to buying a minority stake in Avestha Gengraine Technologies (Avesthagen),...
- Biocon forms JV with Abu Dhabi-based coThe joint-venture with Neopharma is an important milestone for Biocon's global foray.
Load More
